FORM 4
☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
 OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                       
1. Name and Address of Reporting Person * Bienstock Lee 2. Issuer Name and Ticker or Trading Symbol DocGo Inc. [ DCGO ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)_____ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
Chief Operating Officer
(Last)          (First)          (Middle)
C/O DOCGO INC, 35 WEST 35TH STREET, FLOOR 6		 3. Date of Earliest Transaction (MM/DD/YYYY)
5/12/2023
(Street)
NEW YORK, NY 10001		 4. If Amendment, Date Original Filed (MM/DD/YYYY)
 
 6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)        (State)        (Zip)
 Rule 10b5-1(c) Transaction Indication
☐ Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)		 2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)		 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)		 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock  5/12/2023    A    1066 (1) A $0.00  182087  D   
Restricted Stock Unit  5/12/2023    A    121951 (2) A $0.00  304038  D   

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)		 2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)		 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)		 8. Price of Derivative Security
(Instr. 5)		 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Options to purchase Common Stock  $8.61  5/12/2023    A     210843 (3)      (4) 5/12/2033  Common Stock  210843  $0.00  210843  D   

Explanation of Responses:
(1)  These shares reflect fully vested shares of common stock of the Issuer granted in lieu of making Mr. Bienstock's 2023 base salary increase retroactive to January 1, 2023, net of shares withheld for taxes and other payroll withholdings.
(2)  Represents restricted stock units granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"), vesting in four equal annual installments on each of the first four anniversaries of May 12, 2023, in each case, subject to the terms of the Plan. Each restricted stock unit represents the right to receive, upon vesting, one share of Common Stock.
(3)  Represents stock options granted pursuant to the Plan. Each option represents the right to acquire one share of Common Stock.
(4)  The shares subject to the stock options vest and become exercisable in four equal annual installments on each of the first four anniversaries of May 12, 2023, in each case, subject to the terms of the Plan.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Bienstock Lee
C/O DOCGO INC
35 WEST 35TH STREET, FLOOR 6
NEW YORK, NY 10001

Chief Operating Officer

Signatures
/s/ Andre Oberholzer, Attorney-in-Fact for Lee Bienstock 5/16/2023
**Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
DocGo (NASDAQ:DCGO)
Historical Stock Chart
From Sep 2023 to Oct 2023 Click Here for more DocGo Charts.
DocGo (NASDAQ:DCGO)
Historical Stock Chart
From Oct 2022 to Oct 2023 Click Here for more DocGo Charts.